Literature DB >> 17490435

Glycogen synthase kinase 3 activity during development of bone marrow-derived dendritic cells (DCs) essential for the DC function to induce T helper 2 polarization.

Takenori Ono1, Yoshiki Yanagawa, Kazuya Iwabuchi, Katsuya Nonomura, Kazunori Onoé.   

Abstract

Dendritic cells (DCs) polarize naive CD4(+) T cells to either T helper 1 (Th1) or Th2 cells. We examined the role of glycogen synthase kinase 3 (GSK3) activity during DC development from murine bone marrow (BM) cells. DCs were generated by culturing lineage-marker-negative BM cells with granulocyte-macrophage colony-stimulating factor in the presence or absence of a specific inhibitor of GSK3 (Gi), SB415286, for 6 days. DCs generated in the presence (GiDC) or absence (control DC) of SB415286 similarly exhibited a conventional DC phenotype (CD11b(+) B220(-) CD8(-)). These DCs were mixed with allogeneic CD4(+) T cells and the ability to polarize Th1 or Th2 cells was evaluated. The GiDCs exhibited markedly impaired function to induce Th2 polarization compared to control DCs. In contrast, the ability of GiDCs to generate Th1 cells was slightly higher than that of control DCs. CD86 expression and CD40-mediated interleukin-6 production were completely diminished in GiDCs, which might be associated with the impaired ability of the GiDCs to induce Th2 differentiation. These results suggest that the GSK3 activity during DC development is essential for the establishment of the DC function to induce Th2, but not Th1, differentiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17490435      PMCID: PMC2266003          DOI: 10.1111/j.1365-2567.2007.02627.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  32 in total

Review 1.  GSK3 inhibitors: development and therapeutic potential.

Authors:  Philip Cohen; Michel Goedert
Journal:  Nat Rev Drug Discov       Date:  2004-06       Impact factor: 84.694

Review 2.  Crossregulation between Th1 and Th2 cells.

Authors:  P A Morel; T B Oriss
Journal:  Crit Rev Immunol       Date:  1998       Impact factor: 2.214

3.  B7-2 (CD86) is essential for the development of IL-4-producing T cells.

Authors:  A M Ranger; M P Das; V K Kuchroo; L H Glimcher
Journal:  Int Immunol       Date:  1996-10       Impact factor: 4.823

4.  Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3.

Authors:  Michael Martin; Kunal Rehani; Richard S Jope; Suzanne M Michalek
Journal:  Nat Immunol       Date:  2005-07-10       Impact factor: 25.606

5.  Signals from OX40 regulate nuclear factor of activated T cells c1 and T cell helper 2 lineage commitment.

Authors:  Takanori So; Jianxun Song; Katsuji Sugie; Amnon Altman; Michael Croft
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-24       Impact factor: 11.205

Review 6.  LPS, TLR4 and infectious disease diversity.

Authors:  Samuel I Miller; Robert K Ernst; Martin W Bader
Journal:  Nat Rev Microbiol       Date:  2005-01       Impact factor: 60.633

7.  CD28 costimulation promotes the production of Th2 cytokines.

Authors:  I C Rulifson; A I Sperling; P E Fields; F W Fitch; J A Bluestone
Journal:  J Immunol       Date:  1997-01-15       Impact factor: 5.422

8.  Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production.

Authors:  A N Schweitzer; A H Sharpe
Journal:  J Immunol       Date:  1998-09-15       Impact factor: 5.422

9.  Distinct regulation of CD40-mediated interleukin-6 and interleukin-12 productions via mitogen-activated protein kinase and nuclear factor kappaB-inducing kinase in mature dendritic cells.

Authors:  Yoshiki Yanagawa; Kazunori Onoé
Journal:  Immunology       Date:  2006-04       Impact factor: 7.397

10.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.

Authors:  K Inaba; M Inaba; N Romani; H Aya; M Deguchi; S Ikehara; S Muramatsu; R M Steinman
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Glycogen synthase kinase 3: a point of convergence for the host inflammatory response.

Authors:  Huizhi Wang; Jonathan Brown; Michael Martin
Journal:  Cytokine       Date:  2010-11-23       Impact factor: 3.861

2.  Dendritic cell maturation occurs through the inhibition of GSK-3β.

Authors:  Alessandro Alessandrini; Stephanie De Haseth; Michael Fray; Masahiro Miyajima; Robert B Colvin; Winfred W Williams; A Benedict Cosimi; Gilles Benichou
Journal:  Cell Immunol       Date:  2011-04-30       Impact factor: 4.868

3.  Glycogen synthase kinase-3β: a mediator of inflammation in Alzheimer's disease?

Authors:  Jari Koistinaho; Tarja Malm; Gundars Goldsteins
Journal:  Int J Alzheimers Dis       Date:  2011-05-04

4.  Regulation by glycogen synthase kinase-3 of inflammation and T cells in CNS diseases.

Authors:  Eléonore Beurel
Journal:  Front Mol Neurosci       Date:  2011-08-31       Impact factor: 5.639

5.  Decreased store operated Ca2+ entry in dendritic cells isolated from mice expressing PKB/SGK-resistant GSK3.

Authors:  Evi Schmid; Jing Yan; Meerim K Nurbaeva; Antonella Russo; Wenting Yang; Caterina Faggio; Ekaterina Shumilina; Florian Lang
Journal:  PLoS One       Date:  2014-02-11       Impact factor: 3.240

6.  Regulatory Dendritic Cells Induced by K313 Display Anti-Inflammatory Properties and Ameliorate Experimental Autoimmune Encephalitis in Mice.

Authors:  Yan Zhou; Xiao Leng; Xingyan Luo; Chunfen Mo; Qiang Zou; Yang Liu; Yantang Wang
Journal:  Front Pharmacol       Date:  2020-01-28       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.